CARDINAL HEALTH INC (1CAH.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:1CAH - US14149Y1082 - Common Stock
178.1 EUR
+44 (+32.81%)
Overall 1CAH gets a fundamental rating of 5 out of 10. We evaluated 1CAH against 27 industry peers in the Health Care Providers & Services industry. 1CAH has an average financial health and profitability rating. 1CAH is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
1CAH had positive earnings in the past year.
In the past year 1CAH had a positive cash flow from operations.
Of the past 5 years 1CAH 4 years were profitable.
In the past 5 years 1CAH always reported a positive cash flow from operatings.
1.2 Ratios
With a Return On Assets value of 2.89%, 1CAH perfoms like the industry average, outperforming 59.38% of the companies in the same industry.
1CAH has a Return On Invested Capital of 13.13%. This is amongst the best in the industry. 1CAH outperforms 87.50% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for 1CAH is significantly above the industry average of 6.90%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.89% | ||
| ROE | N/A | ||
| ROIC | 13.13% |
ROA(3y)1.81%
ROA(5y)0.94%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)14.18%
ROIC(5y)11.92%
1.3 Margins
1CAH's Profit Margin of 0.68% is on the low side compared to the rest of the industry. 1CAH is outperformed by 68.75% of its industry peers.
Looking at the Operating Margin, with a value of 1.15%, 1CAH is doing worse than 84.38% of the companies in the same industry.
In the last couple of years the Operating Margin of 1CAH has remained more or less at the same level.
Looking at the Gross Margin, with a value of 3.66%, 1CAH is doing worse than 71.88% of the companies in the same industry.
1CAH's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.15% | ||
| PM (TTM) | 0.68% | ||
| GM | 3.66% |
OM growth 3Y6.46%
OM growth 5Y-0.89%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.56%
GM growth 5Y-3.96%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so 1CAH is still creating some value.
The number of shares outstanding for 1CAH has been reduced compared to 1 year ago.
Compared to 5 years ago, 1CAH has less shares outstanding
Compared to 1 year ago, 1CAH has a worse debt to assets ratio.
2.2 Solvency
1CAH has an Altman-Z score of 4.90. This indicates that 1CAH is financially healthy and has little risk of bankruptcy at the moment.
1CAH has a Altman-Z score of 4.90. This is amongst the best in the industry. 1CAH outperforms 93.75% of its industry peers.
The Debt to FCF ratio of 1CAH is 2.03, which is a good value as it means it would take 1CAH, 2.03 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of 1CAH (2.03) is better than 96.88% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 2.03 | ||
| Altman-Z | 4.9 |
ROIC/WACC1.51
WACC8.67%
2.3 Liquidity
1CAH has a Current Ratio of 0.96. This is a bad value and indicates that 1CAH is not financially healthy enough and could expect problems in meeting its short term obligations.
1CAH has a Current ratio of 0.96. This is comparable to the rest of the industry: 1CAH outperforms 56.25% of its industry peers.
A Quick Ratio of 0.52 indicates that 1CAH may have some problems paying its short term obligations.
1CAH's Quick ratio of 0.52 is on the low side compared to the rest of the industry. 1CAH is outperformed by 78.13% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.96 | ||
| Quick Ratio | 0.52 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 16.93% over the past year.
Measured over the past years, 1CAH shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.62% on average per year.
The Revenue has been growing slightly by 4.44% in the past year.
Measured over the past years, 1CAH shows a small growth in Revenue. The Revenue has been growing by 7.80% on average per year.
EPS 1Y (TTM)16.93%
EPS 3Y17.65%
EPS 5Y8.62%
EPS Q2Q%35.64%
Revenue 1Y (TTM)4.44%
Revenue growth 3Y7.06%
Revenue growth 5Y7.8%
Sales Q2Q%22.44%
3.2 Future
The Earnings Per Share is expected to grow by 13.04% on average over the next years. This is quite good.
Based on estimates for the next years, 1CAH will show a quite strong growth in Revenue. The Revenue will grow by 9.35% on average per year.
EPS Next Y18%
EPS Next 2Y15.43%
EPS Next 3Y14.61%
EPS Next 5Y13.04%
Revenue Next Year13.75%
Revenue Next 2Y11.01%
Revenue Next 3Y9.88%
Revenue Next 5Y9.35%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
1CAH is valuated rather expensively with a Price/Earnings ratio of 23.04.
Based on the Price/Earnings ratio, 1CAH is valued a bit more expensive than the industry average as 65.63% of the companies are valued more cheaply.
1CAH is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 25.47, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 18.69, which indicates a rather expensive current valuation of 1CAH.
Based on the Price/Forward Earnings ratio, 1CAH is valued a bit more expensive than the industry average as 65.63% of the companies are valued more cheaply.
When comparing the Price/Forward Earnings ratio of 1CAH to the average of the S&P500 Index (34.42), we can say 1CAH is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.04 | ||
| Fwd PE | 18.69 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, 1CAH is valued a bit more expensive than 75.00% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, 1CAH is valued a bit cheaper than the industry average as 68.75% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 10.95 | ||
| EV/EBITDA | 15.03 |
4.3 Compensation for Growth
1CAH's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
1CAH's earnings are expected to grow with 14.61% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.28
PEG (5Y)2.67
EPS Next 2Y15.43%
EPS Next 3Y14.61%
5. Dividend
5.1 Amount
1CAH has a yearly dividend return of 0.98%, which is pretty low.
Compared to an average industry Dividend Yield of 2.09, 1CAH has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.41, 1CAH's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.98% |
5.2 History
The dividend of 1CAH has a limited annual growth rate of 1.25%.
Dividend Growth(5Y)1.25%
Div Incr YearsN/A
Div Non Decr YearsN/A
5.3 Sustainability
1CAH pays out 31.03% of its income as dividend. This is a sustainable payout ratio.
1CAH's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP31.03%
EPS Next 2Y15.43%
EPS Next 3Y14.61%
BIT:1CAH (11/14/2025, 7:00:00 PM)
178.1
+44 (+32.81%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners88.78%
Inst Owner ChangeN/A
Ins Owners0.22%
Ins Owner ChangeN/A
Market Cap42.31B
Revenue(TTM)234.31B
Net Income(TTM)1.59B
Analysts80.91
Price Target185.7 (4.27%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.98% |
Yearly Dividend1.78
Dividend Growth(5Y)1.25%
DP31.03%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.45%
Min EPS beat(2)1.06%
Max EPS beat(2)15.85%
EPS beat(4)4
Avg EPS beat(4)8.23%
Min EPS beat(4)1.06%
Max EPS beat(4)15.85%
EPS beat(8)8
Avg EPS beat(8)8.86%
EPS beat(12)12
Avg EPS beat(12)10.51%
EPS beat(16)14
Avg EPS beat(16)8.58%
Revenue beat(2)1
Avg Revenue beat(2)2.45%
Min Revenue beat(2)-2.15%
Max Revenue beat(2)7.06%
Revenue beat(4)1
Avg Revenue beat(4)0.63%
Min Revenue beat(4)-2.15%
Max Revenue beat(4)7.06%
Revenue beat(8)3
Avg Revenue beat(8)0.21%
Revenue beat(12)6
Avg Revenue beat(12)0.15%
Revenue beat(16)9
Avg Revenue beat(16)0.6%
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)3.18%
EPS NQ rev (3m)N/A
EPS NY rev (1m)2.03%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)3.27%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)2.16%
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.04 | ||
| Fwd PE | 18.69 | ||
| P/S | 0.21 | ||
| P/FCF | 10.95 | ||
| P/OCF | 9.72 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 15.03 |
EPS(TTM)7.73
EY4.34%
EPS(NY)9.53
Fwd EY5.35%
FCF(TTM)16.27
FCFY9.13%
OCF(TTM)18.33
OCFY10.29%
SpS856.11
BVpS-10.52
TBVpS-54.77
PEG (NY)1.28
PEG (5Y)2.67
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.89% | ||
| ROE | N/A | ||
| ROCE | 18.03% | ||
| ROIC | 13.13% | ||
| ROICexc | 18.95% | ||
| ROICexgc | N/A | ||
| OM | 1.15% | ||
| PM (TTM) | 0.68% | ||
| GM | 3.66% | ||
| FCFM | 1.9% |
ROA(3y)1.81%
ROA(5y)0.94%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)14.18%
ROIC(5y)11.92%
ROICexc(3y)25.43%
ROICexc(5y)20.07%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)19.47%
ROCE(5y)16.36%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y7.19%
ROICexc growth 5Y14.1%
OM growth 3Y6.46%
OM growth 5Y-0.89%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.56%
GM growth 5Y-3.96%
F-Score6
Asset Turnover4.24
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 2.03 | ||
| Debt/EBITDA | 2.54 | ||
| Cap/Depr | 67.18% | ||
| Cap/Sales | 0.24% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 141.8% | ||
| Profit Quality | 279.12% | ||
| Current Ratio | 0.96 | ||
| Quick Ratio | 0.52 | ||
| Altman-Z | 4.9 |
F-Score6
WACC8.67%
ROIC/WACC1.51
Cap/Depr(3y)70.24%
Cap/Depr(5y)63.55%
Cap/Sales(3y)0.24%
Cap/Sales(5y)0.23%
Profit Quality(3y)467.85%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.93%
EPS 3Y17.65%
EPS 5Y8.62%
EPS Q2Q%35.64%
EPS Next Y18%
EPS Next 2Y15.43%
EPS Next 3Y14.61%
EPS Next 5Y13.04%
Revenue 1Y (TTM)4.44%
Revenue growth 3Y7.06%
Revenue growth 5Y7.8%
Sales Q2Q%22.44%
Revenue Next Year13.75%
Revenue Next 2Y11.01%
Revenue Next 3Y9.88%
Revenue Next 5Y9.35%
EBIT growth 1Y22.59%
EBIT growth 3Y13.98%
EBIT growth 5Y6.84%
EBIT Next Year32.48%
EBIT Next 3Y16.76%
EBIT Next 5YN/A
FCF growth 1Y56.43%
FCF growth 3Y-13.35%
FCF growth 5Y3.14%
OCF growth 1Y49.81%
OCF growth 3Y-9.47%
OCF growth 5Y4.11%
CARDINAL HEALTH INC / 1CAH.MI FAQ
What is the fundamental rating for 1CAH stock?
ChartMill assigns a fundamental rating of 4 / 10 to 1CAH.MI.
What is the valuation status of CARDINAL HEALTH INC (1CAH.MI) stock?
ChartMill assigns a valuation rating of 1 / 10 to CARDINAL HEALTH INC (1CAH.MI). This can be considered as Overvalued.
How profitable is CARDINAL HEALTH INC (1CAH.MI) stock?
CARDINAL HEALTH INC (1CAH.MI) has a profitability rating of 4 / 10.
What is the financial health of CARDINAL HEALTH INC (1CAH.MI) stock?
The financial health rating of CARDINAL HEALTH INC (1CAH.MI) is 5 / 10.
How sustainable is the dividend of CARDINAL HEALTH INC (1CAH.MI) stock?
The dividend rating of CARDINAL HEALTH INC (1CAH.MI) is 5 / 10 and the dividend payout ratio is 31.03%.